Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ACXP
ACXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACXP News
Acurx Pharmaceuticals Enters Stock Purchase Agreement
4d ago
seekingalpha
Acurx Pharmaceuticals Renews Media Partnership with New to The Street
Apr 07 2026
Yahoo Finance
Acurx Secures New Patent to Strengthen IP Portfolio
Mar 30 2026
PRnewswire
Acurx Secures New Patent to Strengthen IP Portfolio
Mar 30 2026
Newsfilter
Acurx Pharmaceuticals Q4 2025 Earnings Call Highlights
Mar 13 2026
seekingalpha
Acurx Pharmaceuticals Reports Q4 Loss, Shares Drop
Mar 13 2026
Benzinga
Acurx Pharmaceuticals Reports 2025 Financial Highlights
Mar 13 2026
PRnewswire
Acurx Pharmaceuticals Reports 2025 Financial Results and Clinical Advances
Mar 13 2026
Newsfilter
Acurx Pharmaceuticals Reports Q4 Earnings
Mar 13 2026
seekingalpha
Acurx Pharmaceuticals Shares Pull Back After 107.93% Rally
Mar 12 2026
Benzinga
Petco Reports Strong Q4 Results, Shares Surge
Mar 12 2026
Benzinga
Acurx Pharmaceuticals Stock Surges Amid Positive Developments
Mar 11 2026
Benzinga
ACURX PHARMACEUTICALS ANNOUNCES SALARY REDUCTIONS FOR CEO, EXECUTIVE CHAIRMAN, AND CFO EFFECTIVE APRIL 1, 2026, ACCORDING TO SEC FILING
Mar 09 2026
moomoo
Acurx Advances CDI Patient Program to Phase 3 Trials
Mar 09 2026
PRnewswire
Acurx Launches New Clinical Trial for Recurrent CDI Treatment
Mar 09 2026
Yahoo Finance
Acurx Pharmaceuticals to Release 2025 Financial Results
Feb 16 2026
PRnewswire
Show More News
